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Mortality in people with mental disorders in the Czech Republic: 
a nationwide, register-based cohort study
Dzmitry Krupchanka, Karolína Mladá, Petr Winkler, Yasser Khazaal, Emiliano Albanese
Summary
Background The region of central and eastern Europe is estimated to have high rates of premature mortality due to 
mental disorders. However, epidemiological evidence is scarce and insufficient to inform policy actions and health 
system development. We aimed to assess mortality associated with mental disorders in the Czech Republic. 
Methods We did a nationwide, register-based, retrospective cohort study using routinely collected health data from 
two nationwide registries in the Czech Republic: the register of inpatient discharges (from Jan 1, 1994, to Dec 31, 2013) 
and the causes of death registry (from Jan 1, 1994, to Dec 31, 2014). We first identified all individuals discharged from 
mental health institutions with WHO International Classification of Diseases tenth edition (ICD-10) diagnoses of 
mental and behavioural disorders (from 1994 to 2013). We then did a deterministic individual-level linkage of these 
data with all-cause mortality data for the whole period (1994–2014). Standardised mortality ratios (SMRs) and 95% CIs 
were calculated for the year 2014, comparing deaths in people with mental and behavioural disorders discharged from 
psychiatric hospitals with deaths in the general population.
Findings The final study population comprised 283 618 individuals. 3819 of these individuals died in 2014, 
corresponding to a mortality risk more than two times higher than that of the general population (SMR estimate 2·2; 
95% CI 2·2–2·3). Differences in SMR estimates across diagnostic groups were substantial, with the highest SMR for 
substance use disorders (3·5; 95% CI 3·4–3·7) followed by schizophrenia, schizotypal, and delusional disorders (2·3; 
2·1–2·5), personality disorders (2·3; 2·0–2·6), neurotic, stress-related, and somatoform disorders (1·8; 1·6–1·9), and 
mood (affective) disorders (1·6; 1·5–1·7).
Interpretation Mortality among people with mental disorders in the Czech Republic is markedly higher than in the 
general population. Our findings should stimulate and inform policy in the central and eastern Europe region, as well 
as ongoing national mental health-care reforms in the Czech Republic.
Funding Czech Ministry of Education, Youth and Sports.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 
4.0 license.
Introduction
Excess mortality among people with mental disorders 
is common. Some studies have reported a two-times to 
three-times higher mortality risk in this population 
compared with the general population.1–3 Other studies 
suggest that men and women diagnosed with severe 
mental disorders live, on average, 20 years and 15 years 
less than the general population.4 This substantial gap 
in life expectancy is likely to be increasing because 
mortality continues to fall in the general population 
worldwide, and for all age groups, but not in 
people affected by mental disorders.5 And yet, this 
mortality gap could be largely reduced or even avoided 
altogether.6
According to the 2010 Global Burden of Disease study, 
mental and substance use disorders were the leading 
cause of years lived with disability worldwide, accounting 
for a substantial proportion of all disability-adjusted life-
years.7 In central and eastern Europe, the age-standardised 
disability-adjusted life years (per 100 000 individuals) and 
years of life lost (ie, premature mortality) associated with 
mental and substance use disorders varied markedly 
across countries and were exceptionally high, particularly 
for depressive and alcohol use disorders.7 However, 
evidence about mortality due to mental ill health in central 
and eastern Europe is scarce. During the past 25 years, 
only 23 epidemiological papers (of which 14 are from peer-
reviewed journals) have been published in the whole 
region, which encompasses 24 countries. None of the four 
papers from the Czech Republic focused on mortality, nor 
were they peer-reviewed publications.8 The overall state of 
mental health care in central and eastern Europe is a 
“blind spot on the global mental health map”,8 and one of 
the unknown aspects is whether and to what extent the 
high prevalence of depressive, alcohol, and substance-use 
disorders directly contributes to premature mortality in 
the region.9,10
Mental health-care reform is ongoing in the 
Czech Republic, shifting services from predominantly 
institutionalised care to community-based health service 
provision for a population of ten million inhabitants.11 In 
Nordic countries, deinstitutionalisation was associated 
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with a reduction of the mortality gap between people 
with severe mental illnesses and the general population.4 
However, descriptive data about temporal trends in this 
mortality gap are rarely or poorly collected to assess the 
responsiveness and adequacy of mental health systems 
and to monitor progress.
We aimed to explore mortality associated with mental 
and behavioural disorders in the Czech Republic. In 
particular, we aimed to compare annual mortality, age, 
and causes of death in people with a history of discharge 
from a psychiatric hospital versus the general population 
in 2014.
Methods 
Study design
We did a register-based, retrospective cohort study based 
on individual-level linkage of nationwide data collected in 
the Czech Republic between Jan 1, 1994, and Dec 31, 2014. 
We used two nationwide registries maintained by the 
Institute of Health Information and Statistics of the 
Czech Republic: the register of inpatient discharges and 
the causes of death registry. The National Institute of 
Mental Health was granted full access to data from 
1994 to 2014.
The register of inpatient discharges contains data 
routinely collected by the Institute of Health Information 
and Statistics through the health information system for 
monitoring service provision in the Czech Republic. The 
database contains about 2·3 million hospital records 
for each calendar year, and about 2·5% (nearly 60 000) 
of these datapoints are related to psychiatric hospitalisations 
(defined as inpatient psychiatric admissions, diagnoses, 
treatments, and discharges). These data are recorded on a 
standard form (appendix pp 1,2) that health professionals 
fill out upon patient discharge and send directly to the 
Institute of Health Information and Statistics. 
Completion of this form is mandatory for each patient 
discharged across all health-care facilities. Key clinical 
and health-care information about a patient at the time of 
discharge is reported on the form. The database 
comprises variables including date of birth, sex, marital 
status, occupation, place of and reason for admission, 
primary and comorbid diagnoses, date of admission and 
discharge, date of first symptoms, and type of admission 
and discharge.
Death certificates are routinely used by physicians for 
all deaths in the Czech Republic (appendix pp 3–6). 
Death certificates are promptly sent to the national 
register office. The Czech Statistical Office centrally 
manages the mortality database, which contains the 
following information: place of death, time and date of 
death, age at death, sex, marital status, education, 
nationality, place of residence, primary cause of death 
according to WHO International Classification of 
Diseases tenth edition (ICD-10), whether an autopsy was 
done, and age of spouse at death. The database contained 
about 2·2 million observations from 1994 to 2014.
This study was approved by the Ethical Committee of 
the National Institute of Mental Health on June 15, 2016 
(N 130/16), and complies with the Convention on Human 
Rights and Biomedicine and Act no. 101/2000 on 
protection of personal information.
Selection criteria, data linkage, and data cleaning
We used the database of all-cause inpatient hospital 
discharges to identify all individuals discharged from 
Research in context
Evidence before this study
We searched for and retrieved papers published from Jan 1, 1989, 
to Aug 8, 2016, from MEDLINE, PsycINFO, Embase, Web of 
Science, and the Cochrane Library. Combinations of search terms 
were used, referring to appropriate regional and mental health 
topics (including mental health epidemiology). We applied no 
language restrictions and made all attempts to include sources 
from the grey literature and expert opinions from participating 
countries. We found a substantial shortage of epidemiological 
evidence from the central and eastern Europe region, with only 
23 epidemiological papers, of which 14 were published in peer-
reviewed journals, for the whole region, and no register-based 
study in the whole region about mortality associated with mental 
disorders—an evidence gap we referred to as “a blind spot on the 
global mental health map”. Our scoping review was published in 
2017. 
Added value of this study
This study is, to our knowledge, the first to assess mortality 
associated with mental and behavioural disorders in central and 
eastern Europe by use of deterministic linkage of nationwide 
databases of routinely collected health data. This analysis was 
based on data collected between Jan 1, 1994, and Dec 31, 2014, 
in the Czech Republic. We found that, compared with the 
general population, individuals with a clinical history of mental 
disorders had up to three-times higher mortality, varying by 
age and cause of death. We also describe the record linkage 
procedures and processes across registries to inform and 
stimulate further research in other countries.
Implications of all the available evidence
Our findings have relevant implications for the ongoing mental 
health-care reforms in the Czech Republic, and the methods 
used in this study could prompt similar epidemiological studies 
in other regions with existing mental health registries but 
where research on this topic is still scant. Empirical evidence 
and implementation research are warranted to design and scale 
up specific interventions and to inform structural national 
reforms of mental health services, policy, plans, and 
programmes aimed at closing the mental health mortality gap.
See Online for appendix
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Czech mental health institutions between Jan 1, 1994, 
and Dec 31, 2013, with diagnoses of mental and 
behavioural disorders. We then deterministically linked 
these data with data from the all-cause mortality database; 
all observations were retained. The record-linkage was 
done with an encrypted individual personal identifier 
(birth number). Birth number is an individual personal 
identifier assigned to each resident of the Czech Republic 
at birth or when a person is officially registered as a 
resident of the country. It consists of ten numbers 
combining the six digits of the individual’s date of birth 
(yy/mm/dd) with four random digits. We excluded 
incorrect, implausible (ie, date of discharge after the 
registered date of death), and missing data, and data of 
those individuals who died before Jan 1, 2014. In line 
with other studies on mortality,4,5,12 we also excluded 
people with intellectual disabilities (ICD-10: F70–79) or 
mental disorders due to known physiological conditions 
(F00–09) because premature death is inherent to these 
conditions. We also excluded people younger than 
15 years and older than 84 years to avoid the effects of 
dilution and inflation on mortality.
The final study population consisted of individuals 
with a history of discharge from Czech mental 
health institutions, with relevant ICD-10 diagnoses 
Figure 1: Study selection
452 245 people discharged from Czech mental 
health institutions in 1994–2013 with 
diagnoses of mental disorders (ICD–10, 
F00–99 in register of inpatient 
discharges) 
452 111 records linked with the causes of deaths 
registry and cleaning data
326 495 people alive on Jan 1, 2014
290 579 people who met diagnosis criteria
283 618 people who met age criteria 
                 (15–84 years)
283 618 people included in final study 
population
134 observations with incorrect or missing 
data excluded
125 616 people who died in 1994–2013 
excluded
35 916 people with history of F0x or F7x 
excluded
3966 people <15 years and 2995 people 
>84 years excluded
Study population Deaths
Total 283 618 (100·0%) 3819 (100·0%)
Sex
Men 151 667 (53·5%) 2379 (62·3%)
Women 131 951 (46·5%) 1440 (37·7%)
Age group, years
15–24 24 339 (8·6%) 21 (0·6%)
25–34 56 106 (19·8%) 181 (4·8%)
35–44 62 824 (22·2%) 378 (9·9%)
45–54 52 510 (18·5%) 613 (16·0%)
55–64 52 837 (18·6%) 1115 (29·2%)
65–74 27 355 (9·6%) 1 005 (26·3%)
75–84 7 647 (2·7%) 506 (13·2%)
Marital status
Undisclosed 9318 (3·3%) 156 (4·1%)
Unmarried 130 051 (45·9%) 843 (22·1%)
Married 89 626 (31·6%) 1451 (38·0%)
Divorced 45 421 (16·0%) 1013 (26·5%)
Widowed 9 202 (3·2%) 356 (9·3%)
Employment status
Unemployed 187 875 (66·2%) 2880 (75·5%)
Managers 9197 (3·2%) 89 (2·3%)
Researchers and headworkers 3 182 (1·1%) 36 (1·0%)
Professionals 13 128 (4·7%) 104 (2·7%)
Lower administrative workers 7491 (2·6%) 47 (1·2%)
Employed in services 20 136 (7·1%) 157 (4·1%)
Farm and forest workers 1 673 (0·6%) 20 (0·5%)
Skilled workers 25 716 (9·1%) 307 (8·0%)
Operating personnel 3 655 (1·3%) 37 (1·0%)
Unskilled workers 11 565 (4·1%) 142 (3·7%)
Diagnostic group (ICD-10)*
F10–19 (Disorders due to psychoactive substance 
use)
92 271 (27·2%) 1 899 (41·4%)
F20–29 (Schizophrenia, schizotypal, and delusional 
disorders)
49 822 (14·8%) 724 (15·8%)
F30–39 (Mood [affective] disorders) 38 061 (11·3%) 616 (13·4%)
F40–48 (Neurotic, stress-related, and somatoform 
disorders)
92 995 (27·5%) 958 (20·9%)
F50–59 (Behavioural syndromes associated with 
physiological disturbances and physical factors)
6 001 (1·8%) 26 (0·6%)
F60–69 (Disorders of adult personality and behavior) 32 993 (9·8%) 309 (6·7%)
F80–89 (Disorders of psychological development) 1 393 (0·4%) 1 (0·0%)
F90–99 (Behavioural emotional disorders with onset 
usually occurring in childhood or adolescence)
24 152 (7·2%) 54 (1·2%)
Individuals with a history of multiple diagnoses 43 862 (15·5%) 609 (15·9%)
Data are n (%). The study population comprises individuals with a history of discharge from Czech mental health 
institutions between Jan 1, 1994, and Dec 31, 2013, with ICD-10 recorded diagnoses of mental disorders, and who 
were alive on Jan 1, 2014. Mortality data shown for individuals within the study population who died between 
Jan 1, 2014, and Dec 31, 2014. ICD-10=WHO International Classification of Diseases tenth edition. *Individuals with 
several hospital admissions with diagnoses from different diagnostic groups were included several times in different 
groups accordingly. 
Table 1: Sociodemographic characteristics of the study population
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(F10–19; F20–29; F30–39; F40–48; F50–59; F60–69; 
F80–89; and F90–99; and not F00–09 and F70–79), and 
who were alive on Jan 1, 2014.
Data analysis
We analysed all-cause mortality in 2014 (all deaths 
occurring between Jan 1, 2014, and Dec 31, 2014) 
for individuals with and without a history of discharge 
from psychiatric inpatient facilities, and calculated the 
standardised mortality ratio (SMR) between these 
two groups (with 95% CI) by age and sex for each group 
of mental disorders and for individuals with a history of 
multiple diagnoses. The formula for the SMR calculation 
is provided in the appendix (p 11). We plotted the 
percentage distribution of deaths by age for each 
diagnostic category, for the whole group, separately for 
men and women, and in the general population. We also 
did χ² tests and post-hoc two-sample z tests for proportions 
to make formal comparisons of age distributions with the 
general population. Finally, we derived and analysed 
cause of death for different groups of mental and 
behavioural disorders and presented mortality ratios with 
95% CIs for each diagnostic category and for the whole 
group.
All statistical analyses were done in Stata IC 14, 
combined with Microsoft Access and Oracle database 
9i Release 2 (version 9.0.2) to increase data management 
capability.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication. 
Results
The final study population comprised 283 618 individuals 
(figure 1). Sociodemographic characteristics of the study 
population are summarised in table 1. The mean age was 
45·3 years (SD 15·4), and the proportion of men to women 
was similar. 187 875 (66·2%) people were unemployed and 
89 626 (31·6%) were married. Mental and behavioural 
disorders due to psychoactive substance use (F10–19; 
representing 27·2% of primary diagnoses at discharge) and 
those classified as neurotic, stress-related, and somatoform 
disorders (F40–48; 27·5%) were two major subgroups, 
followed by schizophrenia, schizotypal, and delusional 
disorders (F20–29; 14·8%), and mood (affective) disorders 
(F30–39; 11·3%). 43 862 (15·5%) people had a history of 
multiple diagnoses of mental and behavioural disorders. 
Additional information about this group is presented in the 
appendix (pp 7,8).
3819 individuals within the study population died 
between Jan 1, 2014, and Dec 31, 2014. Among those who 
died, 62·3% were men, 75·5% were unemployed, and 
38·0% were married (table 1).
In 2014, individuals who had received a diagnosis of any 
mental disorder were, on average, significantly younger 
when they died than those in the general population 
(p<0·0001; figure 2). This difference remained when 
Figure 2: Age at death in the study population versus the general population in 2014
The study population comprises people with a history of discharge from Czech mental health institutions between 
Jan 1, 1994, and Dec 31, 2013, with ICD-10 recorded diagnoses of mental disorders and who were alive on 
Jan 1, 2014. ICD-10=WHO International Classification of Diseases tenth edition. *Post-hoc two-sample Z test for 
proportion showed significant differences between the study population and the general population (p<0·0001), 
except for age groups of 15–24 years (p=0·10), 25–29 years (p=0·23), and 65–69 years (p=0·87). †χ² goodness of fit 
test showed significant differences between the study population and the general population (p<0·0001). 
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Study population General population Mortality ratio 
(95% CI)
Certain infectious and parasitic diseases 
(A00–B99)
58 (1·5%) 1245 (1·6%) 1·4 (0·9–2·2)
Neoplasms (C00–D48) 718 (18·8%) 24 182 (32·0%) 0·9 (0·8–1·1)
Endocrine, nutritional, and metabolic 
diseases (E00–90)
102 (2·7%) 2789 (3·7%) 1·1 (0·5–5·6)
Mental and behavioural disorders (F00–F99) 66 (1·7%) 629 (0·8%) 3·2 (2·1–4·9)
Diseases of the nervous system (G00–99) 96 (2·5%) 1906 (2·5%) 1·6 (1·1–2·1)
Diseases of the circulatory system (I00–99) 1225 (32·1%) 29 637 (39·2%) 1·3 (1·2–1·4)
Diseases of the respiratory system (J00–99) 235 (6·1%) 4430 (5·9%) 1·6 (1·3–2·0)
Diseases of the digestive system (K00–93) 458 (12·0%) 3813 (5·0%) 3·7 (3·1–4·3)
Symptoms, signs, and abnormal clinical and 
laboratory findings (R00–99)
75 (2·0%) 887 (1·2%) 2·6 (1·7–2·8)
Other causes of death* 49 (1·3%) 1270 (1·7%) 1·2 (0·7–1·9)
External causes of morbidity and mortality 
(V01–Y98)
737 (19·3%) 4745 (6·3%) 4·8 (4·3–5·4)
    Intentional self-harm (X60–84) 312 (8·2%) 1488 (1·8%) 6·5 (5·3–7·8)
    Other external causes of morbidity and 
mortality (V01–X56, X95–Y98)
425 (11·1%) 3257 (4·5%) 4·0 (3·4–4·7)
Total 3819 (100·0%) 75 533 (100·0%) 2·2 (2·1–2·9)
Data are n (%), unless otherwise stated. The study population comprises individuals with a history of discharge from Czech 
mental health institutions between Jan 1, 1994, and Dec 31, 2013, with ICD-10 recorded diagnoses of mental disorders, 
and who were alive on Jan 1, 2014. Numbers are expressed as percentages of all deaths. Mortality ratios calculated 
comparing the study population with the general population. ICD-10=WHO International Classification of Diseases tenth 
edition. *Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism 
(D50–89); diseases of the skin and subcutaneous tissue (L00–99); diseases of the musculoskeletal system and connective 
tissue (M00–99); diseases of the genitourinary system (N00–99); congenital malformations deformations and 
chromosomal abnormalities (Q00–99); and pregnancy, childbirth, and the puerperium (O00–99).
Table 2: Distribution of causes of death in the general population and among the study population in 2014
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men and women were compared separately (p<0·0001; 
appendix p 9). The peak in mortality (the age group with 
the highest proportion of deaths) among those with a 
history of mental illness was 60–64 years, and more than 
two decades later (80–84 years) in the general population 
(figure 2).
Mortality ratios with 95% CIs and the proportion of 
deaths for each diagnostic category of the study population 
and the general population in 2014 are presented in 
table 2 and in the appendix (p 10). Distributions of age at 
death for each diagnostic group are presented in figure 3, 
and separately for men and women in the appendix. 
Peaks in mortality varied across the disorders but 
appeared at earlier ages than in the general population 
for all groups of diagnoses. The χ² and post-hoc test 
of proportions rejected the null hypothesis of no 
difference in the distribution of data in age categories 
when comparing the whole study population and each 
diagnostic category separately with the general population 
(p<0·0001).
The overall SMR for individuals treated in hospital for 
any mental disorder compared with the general population 
was estimated at 2·2 (95% CI 2·2–2·3) and differed across 
diagnostic groups (table 3). The highest ratios were for 
mental and behavioural disorders due to psychoactive 
substance use (F10–19; SMR 3·5; 95% CI 3·4–3·7); 
schizophrenia, schizotypal, and delusional disorders 
(F20–29; 2·3; 2·1–2·5); and personality disorders (F60–69; 
2·3; 2·0–2·6); followed by neurotic, stress-related, and 
somatoform disorders (F40–48; 1·8; 1·6–1·9) and mood 
(affective) disorders (F30–39; 1·6; 1·5–1·7). Those with a 
history of multiple diagnoses had an estimated SMR of 
2·9 (95% CI 2·7–3·2; table 3). 
Although the distribution of cause of death varied 
across the diagnostic groups of mental disorders, 
cardiovascular diseases (ICD-10 I00–99) were the leading 
cause of death in all groups and in the general population 
(contributing to 32·1% of deaths in the study population 
and 39·2% in the general population), with a mortality 
ratio of 1·3 (95% CI 1·2–1·4; table 2). However, the 
proportion of deaths due to external causes was more 
than three times higher in people with a history of 
discharge from a psychiatric hospital for mental disorders 
than in the general population (19·3% vs 6·3%; mortality 
ratio 4·8 [95% CI 4·3–5·4]), and the proportion of 
deaths due to intentional self-harm was even higher 
(8·2% vs 1·8%; 6·5 [95% CI 5·3–7·8]). Mortality directly 
caused by mental and behavioural disorders was higher 
among individuals with a history of discharge from a 
psychiatric hospital than among the general population 
(mortality ratio 3·2 [95% CI 2·1–4·9]), as was death 
because of symptoms, signs, and abnormal clinical and 
laboratory findings (2·6 [1·7–2·8]), death from diseases 
of the nervous system (1·6 [1·1–2·1]), and death from 
diseases of the respiratory system (1·6 [95% CI 1·3–2·0]; 
table 2). The proportion of individuals with diagnosed 
mental disorders who died from gastrointestinal diseases 
(K00–93) was substantially higher than in the general 
population (mortality ratio 3·7 [95% CI 3·1–4·3]), 
especially within the subgroup of those with substance 
use disorders (19·2% in those with substance use 
disorders vs 5·0% in the general population). Mortality 
due to other health conditions did not differ substantially 
(table 3; appendix p 10).
Discussion
The results of this study show that people with a history 
of discharge from a psychiatric hospital in the 
Czech Republic had increased all-cause mortality in 
2014 compared with the general population. Individuals 
diagnosed with mental and behavioural disorders died 
significantly earlier than individuals in the general 
population, and although the leading cause of death 
(cardiovascular diseases) was consistent, mortality from 
other causes markedly varied between the two groups.
Figure 3: Age at death in the general population in 2014 and among each diagnostic category of the study 
population
The study population comprises people with a history of discharge from Czech mental health institutions between 
Jan 1, 1994, and Dec 31, 2013, with ICD-10 recorded diagnoses of mental disorders and who were alive on Jan 1, 2014.  
ICD-10=WHO International Classification of Diseases tenth edition. *χ² goodness of fit test showed significant 
differences between the study population and the general population (p<0·0001).
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General population
Disorders due to psychoactive substance use*
Schizophrenia, schizotypal, and delusional disorders*
Mood (affective) disorders*
Neurotic, stress-related, and somatoform disorders*
Disorders of adult personality and behaviour*
History of multiple diagnoses*
SMR 95% CI
General population 1 (ref) ··
Any diagnoses 2·2 2·2–2·3
Disorders due to psychoactive substance use (F10–19) 3·5 3·4–3·7
Schizophrenia, schizotypal, and delusional disorders (F20–29) 2·3 2·1–2·5
Mood (affective) disorders (F30–39) 1·6 1·5–1·7
Neurotic, stress-related and somatoform disorders (F40–48) 1·8 1·6–1·9
Disorders of adult personality and behaviour (F60–69) 2·3 2·0–2·6
Individuals with a history of multiple diagnoses 2·9 2·7–3·2
The study population comprises individuals with a history of discharge from Czech mental health institutions between 
Jan 1, 1994, and Dec 31, 2013, with ICD-10 recorded diagnoses of mental disorders, and who were alive on Jan 1, 2014.  
ICD-10=WHO International Classification of Diseases tenth edition. SMR=standardised (by age and sex) mortality ratio. 
Individuals with more than several hospital admissions with diagnoses from different diagnostic groups were included 
several times into different groups accordingly. SMRs for ICD-10 categories F50–59 and F80–89 were not calculated 
because the number of people in these two categories was not sufficient for deriving any meaningful estimations. 
Table 3: Standardised annual mortality ratios of the study population in comparison with the general 
population in 2014
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This study is, to our knowledge, the first to analyse 
mortality associated with mental illness in central and 
eastern Europe. Major strengths of our study include the 
comprehensiveness of the data, the large sample size, and 
low amounts of missing data. However, some limitations 
are worth noting. First, it was not possible to do a formal 
and separate validation of the codes and algorithms used 
to select the study population, and our linkage procedures, 
coding variations, and the exact coverage of the registries 
were not formally assessed. The population of individuals 
with a history of admission to hospital because of a mental 
illness might have differing mortality to those who have 
never been admitted to hospital, or treated, or both, and 
the direction of this difference requires additional 
research. Overestimation of mortality is possible since 
individuals with a history of discharge from a psychiatric 
hospital represent more severe cases of illness than do 
those without. However, there could also be fewer deaths 
among patients treated in hospital than among those 
never treated in hospital because inpatients would receive 
more intense treatment. We used data of patients 
discharged from inpatient facilities, where patients with 
mild mental and behavioural disorders are less likely to be 
treated, and our findings should therefore be generalised 
with caution to similar populations only. Second, our 
study design excluded individuals who died before 2014. 
This exclusion might have diluted the true effect of mental 
disorders on mortality through selection of individuals 
with a longer disease duration. Additionally, our results 
might underestimate mortality because individuals with 
substance use disorders and with somatic comorbidities, 
and thus plausibly shorter survival with disease, could 
have been systematically under-represented. Another 
potential limitation is that we were not able to take into 
account all the important risk factors beyond the presented 
mental disorders—for example, tobacco smoking. 
Although nicotine dependence is an important condition 
with additional health risks, it is rarely recorded in the 
Czech Republic, and separate analysis of this risk factor 
was not possible.
Comparisons with studies done in other countries are 
not straightforward because the nature and purpose of 
registries, as well as access to and linkage of registry data, 
markedly differ between health systems and regions. 
Moreover, register-based studies are affected by unknown 
geographical and temporal variations in diagnostic and 
coding practices, and quality of data, which are not 
purposely collected to address and answer specific 
research questions.13 Nevertheless, our results are mostly 
in line with those of previous studies. Evidence from 
recent systematic reviews showing the marked, 
disproportionate mortality associated with mental and 
neurological disorders is robust and consistent across 
several studies done in Scandinavia, western Europe, 
North America, Asia, and Australia.14 The mortality ratio 
in individuals diagnosed with mental and neurological 
disorders compared with the general population was 
shown to be high among individuals with substance use 
disorders (opiate use: 14·7 [95% CI 12·8–16·5];15 
amphetamine: 6·2 [4·6–8·3];16 alcohol: 4.6 [2·7–7·7]),3 
anorexia nervosa (5·8 [4·2–8·3]),17 schizophrenia 
(2·5 [2·2–2·4] to 4·7 [4·1–5·3]),18,19 depression 
(1·5 [1·4–1·6]),20 and other conditions (acute and transient 
psychosis: 4·7 [4·1–5·3]; bipolar disorder: 3·3 [2·8–3·8]).19 
The complex association between physical and mental 
health provides some potential explanations for this gap in 
mortality.21 Mental and somatic disorders often co-occur 
because of shared risk factors and common pathological 
pathways. Poor mental health might delay help seeking 
and might affect the detection, diagnosis, and prognosis of 
both communicable and non-communicable diseases. 
Moreover, although chronic diseases can cause or worsen 
mental disorders because of the associated disability and 
burden (and through the side-effects of medications on 
the CNS), access to care, help-seeking, and adherence to 
treatment might be poor in people with mental disorders. 
Poor longitudinal continuity of care,22 loneliness,23 an 
unhealthy lifestyle, poor health literacy, absence of health-
promoting behaviours, structural issues, and social 
determinants of health (eg, relative poverty) are among 
other potential factors contributing to the excess mortality.2 
A combination of all these factors might explain the 
increased mortality due to different health conditions, 
particularly due to symptoms, signs, and abnormal clinical 
and laboratory findings, diseases of the nervous, 
respiratory, and circulatory systems, and directly caused by 
mental and behavioural disorders. Increased mortality due 
to gastrointestinal disorders might be linked to increased 
liver and gastric problems associated with alcohol and 
substance use disorders.24,25 Finally, schizophrenia and 
common mental health disorders such as depression 
and substance abuse are the main proximal risk factors for 
suicide, which is the second leading cause of death in 
young adults (<30 years) globally.3,26 The high mortality 
due to intentional self-harm in our study corresponds with 
other research showing heightened rates of suicide, 
unintentional injuries,27 and likelihood of being a victim of 
homicide among people with mental disorders, which 
might partially explain the differences in mortality from 
external causes of death.28
Our data provide a strong evidence base for the 
substantial life expectancy gap in people with mental 
disorders in the central and eastern Europe region. Our 
findings are particularly important in the context of the 
ongoing mental health-care reforms in the 
Czech Republic. Strengthening of suicide prevention 
efforts and provision of better mental and physical care 
for people with mental illnesses, as outlined in the WHO 
Comprehensive Mental Health Action Plan 2013–2020, is 
crucial.29 Mortality and its monitoring over time have 
been included among the key preliminary indicators of 
the proposed mental health national plan in the Czech 
Republic to closely monitor progress in quality of mental 
health care.11 Data will be routinely collected to assess the 
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development of mental health-care services in the 
country. Because of the scarcity of epidemiological 
evidence from other countries in central and eastern 
Europe, further research is urgently needed to inform 
and propel mental health promotion, disease prevention, 
and policy and health-systems responses aimed at closing 
the life expectancy gap in people with mental disorders, 
and addressing the largely unmet mental health needs in 
the region.
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